Intensity Therapeutics Inc (NASDAQ: INTS) kicked off on Friday, up 7.45% from the previous trading day, before settling in for the closing price of $0.38. Over the past 52 weeks, INTS has traded in a range of $0.19-$3.18.
Healthcare Sector giant saw their annual sales slid by -23.29% over the last five years. While this was happening, its average annual earnings per share was recorded 70.60%. With a float of $53.63 million, this company’s outstanding shares have now reached $60.06 million.
Intensity Therapeutics Inc (INTS) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Intensity Therapeutics Inc is 10.72%, while institutional ownership is 4.92%.
Intensity Therapeutics Inc (INTS) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.22 earnings per share (EPS), higher than consensus estimate (set at -0.23) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 70.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.02% during the next five years compared to -23.29% drop over the previous five years of trading.
Intensity Therapeutics Inc (NASDAQ: INTS) Trading Performance Indicators
Take a look at Intensity Therapeutics Inc’s (INTS) current performance indicators. Last quarter, stock had a quick ratio of 3.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.63, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.21 in one year’s time.
Technical Analysis of Intensity Therapeutics Inc (INTS)
Analysing the last 5-days average volume posted by the [Intensity Therapeutics Inc, INTS], we can find that recorded value of 1.87 million was lower than the volume posted last year of 9.92 million. As of the previous 9 days, the stock’s Stochastic %D was 26.20%.
During the past 100 days, Intensity Therapeutics Inc’s (INTS) raw stochastic average was set at 14.34%, which indicates a significant increase from 13.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0697 in the past 14 days, which was higher than the 0.0498 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3526, while its 200-day Moving Average is $0.8109. Now, the first resistance to watch is $0.4241. This is followed by the second major resistance level at $0.4400. The third major resistance level sits at $0.4645. If the price goes on to break the first support level at $0.3837, it is likely to go to the next support level at $0.3592. Now, if the price goes above the second support level, the third support stands at $0.3433.
Intensity Therapeutics Inc (NASDAQ: INTS) Key Stats
The company with the Market Capitalisation of 24.52 million has total of 60,065K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -16,270 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -2,670 K.
